These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16600214)

  • 21. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect.
    Corso A; Ferretti E; Lunghi M; Zappasodi P; Mangiacavalli S; De Amici M; Rusconi C; Varettoni M; Lazzarino M
    Cancer; 2005 Jul; 104(1):118-25. PubMed ID: 15895374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.
    Tanaka Y; Abe M; Hiasa M; Oda A; Amou H; Nakano A; Takeuchi K; Kitazoe K; Kido S; Inoue D; Moriyama K; Hashimoto T; Ozaki S; Matsumoto T
    Clin Cancer Res; 2007 Feb; 13(3):816-23. PubMed ID: 17289872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bone disease in multiple myeloma and its mechanism].
    Abe M
    Clin Calcium; 2006 Apr; 16(4):565- 71. PubMed ID: 16582506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of the osteoclast in pathogenesis of multiple myeloma].
    Zhang JH; Fu JX; Zhang XH; Sun Y
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):323-6. PubMed ID: 17877161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
    J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation.
    Ichikawa H; Murakami A; Aggarwal BB
    Mol Cancer Res; 2006 Apr; 4(4):275-81. PubMed ID: 16603641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.
    Gunn WG; Conley A; Deininger L; Olson SD; Prockop DJ; Gregory CA
    Stem Cells; 2006 Apr; 24(4):986-91. PubMed ID: 16293576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the bone marrow microenvironment in multiple myeloma.
    Roodman GD
    J Bone Miner Res; 2002 Nov; 17(11):1921-5. PubMed ID: 12412796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.
    Chauhan D; Uchiyama H; Urashima M; Yamamoto K; Anderson KC
    Stem Cells; 1995 Aug; 13 Suppl 2():35-9. PubMed ID: 8520509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone.
    Sandra F; Hendarmin L; Kukita T; Nakao Y; Nakamura N; Nakamura S
    Oral Oncol; 2005 Jul; 41(6):637-44. PubMed ID: 15935726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells.
    Angelucci A; Garofalo S; Speca S; Bovadilla A; Gravina GL; Muzi P; Vicentini C; Bologna M
    Endocr Relat Cancer; 2008 Mar; 15(1):91-100. PubMed ID: 18310278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p38alpha-selective MAP kinase inhibitor reduces tumor growth in mouse xenograft models of multiple myeloma.
    Medicherla S; Reddy M; Ying J; Navas TA; Li L; Nguyen AN; Kerr I; Hanjarappa N; Protter AA; Higgins LS
    Anticancer Res; 2008; 28(6A):3827-33. PubMed ID: 19189670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cells.
    Vincent L; Jin DK; Karajannis MA; Shido K; Hooper AT; Rashbaum WK; Pytowski B; Wu Y; Hicklin DJ; Zhu Z; Bohlen P; Niesvizky R; Rafii S
    Cancer Res; 2005 Apr; 65(8):3185-92. PubMed ID: 15833849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
    Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
    Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK.
    Hecht M; Heider U; Kaiser M; von Metzler I; Sterz J; Sezer O
    Br J Haematol; 2007 Aug; 138(4):446-58. PubMed ID: 17593251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone destruction in multiple myeloma.
    Matsumoto T; Abe M
    Ann N Y Acad Sci; 2006 Apr; 1068():319-26. PubMed ID: 16831932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients.
    Zannettino AC; Farrugia AN; Kortesidis A; Manavis J; To LB; Martin SK; Diamond P; Tamamura H; Lapidot T; Fujii N; Gronthos S
    Cancer Res; 2005 Mar; 65(5):1700-9. PubMed ID: 15753365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CAMP-response element-binding protein mediates tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in endothelial cells.
    Ono H; Ichiki T; Ohtsubo H; Fukuyama K; Imayama I; Iino N; Masuda S; Hashiguchi Y; Takeshita A; Sunagawa K
    Hypertens Res; 2006 Jan; 29(1):39-47. PubMed ID: 16715652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways.
    Takami M; Cho ES; Lee SY; Kamijo R; Yim M
    FEBS Lett; 2005 Jan; 579(3):832-8. PubMed ID: 15670856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.